Buy SUN PHARMA ADVANCED RESEARCH COMPANY
|Buy Range||120 – 138|
|Target||170 – 190|
|Duration||3 – 4 Months|
|Potential Returns^||35 – 50%|
|CP#||Idea||Buy Range||Target||StopLoss*||Duration||Potential Returns^|
|136.9||BUY||120 – 138||170 – 190||105||3 – 4 Months||35 – 50%|
# CP – closing price on Apr 13, 2020
* Maintain recommended StopLoss by daily closing basis.
Once 1st target hit, reset StopLoss at 153.
^ Potential returns are calculated based on the median of buy range.
Verify Sun Pharma Advanced Investment Advice
To verify our authenticity and credibility, do check the trading position update and recommendation timestamp. Be assured such records are permanent and irreversible.
COMPANY OVERVIEW - SUN PHARMA ADVANCED RESEARCH COMPANY
Incorporated in 2006, Sun Pharma Advanced Research Company Limited is an innovative clinical stage bio-pharmaceutical company engaged in creation of new drugs and delivery systems. They works o innovation and new product development for India and global markets. The pharmaceutical company undertake projects in research and technology for new chemical entities or new molecules, and novel drug delivery systems. The Sun Pharma Advanced Research Company is a subsidiary of Shanghvi Finance Pvt. Limited.
|Sectoral Index||Nifty 500|
SUN PHARMA ADVANCED RESEARCH TECHNICAL ANALYSIS (WEEKLY)
- In the weekly chart, Sun Pharma Advanced Research Company Limited (NSE: SPARC) share price recently make Upside Breakout above the upper bound of a falling range as shown above.
- SPARC stock price has been holding above all important Moving Average parameters.
- Volumes have gone up along with SPARC price rise.
- The stock price of Sun Pharma Advanced Research Company limited had formed well defined Broadening Triangle Pattern over the last 15 months, and recent price movement may reach Upper boundary of this larger consolidation pattern in the next few months.
SUN PHARMA ADVANCED RESEARCH TECHNICAL ANALYSIS (DAILY)
- Higher Tops and Higher Bottoms at Daily Chart shows bullishness. Sun Pharma Advanced Research Company Ltd (NSE: SPARC) stock price had given the trendline breakout further indicates positive sign.
- Buying momentum are indicating probable further rise as ADX and +DI crossing above 30 for SPARC stock.
- Overall a positive chart and momentum pattern indicates an opportunity for a BUY trade.
- You can Buy Sun Pharma Advanced Research Company Limited having target 170 – 190 as mentioned above.
SUN PHARMA ADVANCED INVESTMENT UPDATE - POSITION & ACTIVITIES
Follow This Post On Social Media
💡 Sun Pharma Advanced Research (NSE: #SPARC) technical analysis - Upside Breakout of a falling range and buying momentum indicates probable further rise.— Goodluck Capital (@CapitalGoodluck) April 15, 2020
⬆️ Buy range 120-138, Target ₹ 170-190, #Stoploss 105, expected #Profit 35-50%
● Original post https://t.co/X09oXxzuLG